drugset / Trial / NCT01929343

Lidocaine Infusion as a Treatment for Cocaine Relapse and Craving

NCT01929343

RandomizedParallel-groupQuadruple-blindTreatment

Summary

We propose that the systemic administration of lidocaine following the induction of cue-induced craving, relative to saline plus cue-induced craving or lidocaine without cue-induced craving, will block the reconsolidation of cue memories. This will lead to a reduction in cue-induced craving upon repeated testing as well as subsequent cocaine use and basal craving.

Timeline

Start
2014-01
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications